Clinical and Genetic Risk Factors of Long-Term Outcomes after Encephaloduroarteriosynangiosis in Moyamoya Disease in China-Reference-Cited by-同舟云学术

Clinical and Genetic Risk Factors of Long-Term Outcomes after Encephaloduroarteriosynangiosis in Moyamoya Disease in China

Published:2021-07 Issue:7 Volume:30 Page:105847
ISSN:1052-3057
Container-title:Journal of Stroke and Cerebrovascular Diseases
language:en
Short-container-title:Journal of Stroke and Cerebrovascular Diseases

Author:

Wang Xiaotong,Zhang Zhengshan,Wang Yue,Zou Zhengxing,Ta Na,Hao Fangbin,Shang Mengke,Li Desheng,Zeng Fanxin,Han Cong,Nie Fangfang,Bao Xiangyang,Yang Yuetian,Wang Hui,Liang Man,Yang Rimiao,Ou Lanxin,Wen Lu,Yang Zhibin,Liu Wanyang,Duan Lian

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Clinical Neurology,Rehabilitation,Surgery

Reference26 articles.

1. Moyamoya disease: current concepts and future perspectives;Kuroda;Lancet Neurol,2008

2. Treatment of Spontaneous Occlusion of the Circle of W, Health Labour Sciences Research Grant for Research on Measures for Infractable D. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis);Research Committee on the;Neurol Med Chir (Tokyo),2012

3. Clinical features, surgical treatment, and long-term outcome in pediatric patients with moyamoya disease in China;Bao;Cerebrovasc Dis,2015

4. The frequency of postoperative stroke in moyamoya disease following combined revascularization: a single-university series and systematic review;Kazumata;J Neurosurg,2014

5. Association Between p.R4810K Variant and Long-Term Clinical Outcome in Patients With Moyamoya Disease;Ge;Front Neurol,2019

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of hypertension on clinical outcomes in moyamoya disease: a multicenter, propensity score-matched analysis;Acta Neurochirurgica;2024-09-13

2. The Association of Heterozygous p.R4810K of RNF213 and Long-Term Unfavorable Outcomes after Encephaloduroarteriosynangiosis in Chinese Pediatric Patients with Moyamoya Disease;Human Mutation;2024-04-24

3. RNF213 in moyamoya disease: Genotype–phenotype association and the underlying mechanism;Chinese Medical Journal;2024-01-19

4. The quest for a geo-environmental factor in Moyamoya angiopathy: Is arsenic the elusive environmental agent?;Medical Hypotheses;2024-01

5. Long-term outcomes after conservative and EDAS treatment for 111 elderly patients with moyamoya disease: longitudinal and cross-sectional study;Journal of Neurosurgery;2023-09-01